Cargando…
Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry
INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whe...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513216/ https://www.ncbi.nlm.nih.gov/pubmed/26041497 http://dx.doi.org/10.1007/s40264-015-0302-z |
_version_ | 1782382609157849088 |
---|---|
author | de Jonge, Linda de Walle, Hermien E. K. de Jong-van den Berg, Lolkje T. W. van Langen, Irene M. Bakker, Marian K. |
author_facet | de Jonge, Linda de Walle, Hermien E. K. de Jong-van den Berg, Lolkje T. W. van Langen, Irene M. Bakker, Marian K. |
author_sort | de Jonge, Linda |
collection | PubMed |
description | INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whether medicines used during pregnancy are taken according to the prescribed dosage and duration. METHODS: We performed a cross-sectional study in a population-based congenital anomaly register (EUROCAT Northern Netherlands). We included 202 women who had at least one prescription during their pregnancy and who gave birth between 2009 and 2011. Compliance with the prescribed medication was verified by telephone interview. We calculated the compliance rates for several medication groups by dividing the number of mothers who confirmed they had taken the medication by the total number to whom it had been prescribed. Compliance was positive if the mother confirmed she took the medication, even if she only took one of several prescriptions from the same medication group. For each prescription taken, we also determined whether her use conformed to the prescribed dosage and duration. RESULTS: During the first trimester, the compliance rates ranged from 0.84 (for chronic diseases) to 0.92 (for pregnancy-related symptoms). Most of the medications actually taken were used at the prescribed dosage or lower. More than half of the medications actually taken were used for the duration prescribed or shorter. CONCLUSION: Prescription records are generally a relatively reliable source of data for research into associations between medication use in pregnancy and congenital anomalies compared with other data sources. Pharmacy records of medication use in pregnancy might represent an overestimation, which should be taken into account. However, our results show that, except for ‘corticosteroids, dermatological preparations’; ‘ear, eye, nose and throat preparations’; and ‘anxiolytics, hypnotics and sedatives’, this overestimation generally seems minimal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40264-015-0302-z) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-4513216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-45132162015-07-24 Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry de Jonge, Linda de Walle, Hermien E. K. de Jong-van den Berg, Lolkje T. W. van Langen, Irene M. Bakker, Marian K. Drug Saf Original Research Article INTRODUCTION AND AIM: Data from prescription databases are increasingly being used to study associations between maternal medications used in pregnancy and congenital anomalies. We therefore investigated the extent to which prescriptions reflect the actual use of medication during pregnancy, and whether medicines used during pregnancy are taken according to the prescribed dosage and duration. METHODS: We performed a cross-sectional study in a population-based congenital anomaly register (EUROCAT Northern Netherlands). We included 202 women who had at least one prescription during their pregnancy and who gave birth between 2009 and 2011. Compliance with the prescribed medication was verified by telephone interview. We calculated the compliance rates for several medication groups by dividing the number of mothers who confirmed they had taken the medication by the total number to whom it had been prescribed. Compliance was positive if the mother confirmed she took the medication, even if she only took one of several prescriptions from the same medication group. For each prescription taken, we also determined whether her use conformed to the prescribed dosage and duration. RESULTS: During the first trimester, the compliance rates ranged from 0.84 (for chronic diseases) to 0.92 (for pregnancy-related symptoms). Most of the medications actually taken were used at the prescribed dosage or lower. More than half of the medications actually taken were used for the duration prescribed or shorter. CONCLUSION: Prescription records are generally a relatively reliable source of data for research into associations between medication use in pregnancy and congenital anomalies compared with other data sources. Pharmacy records of medication use in pregnancy might represent an overestimation, which should be taken into account. However, our results show that, except for ‘corticosteroids, dermatological preparations’; ‘ear, eye, nose and throat preparations’; and ‘anxiolytics, hypnotics and sedatives’, this overestimation generally seems minimal. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s40264-015-0302-z) contains supplementary material, which is available to authorized users. Springer International Publishing 2015-06-04 2015 /pmc/articles/PMC4513216/ /pubmed/26041497 http://dx.doi.org/10.1007/s40264-015-0302-z Text en © The Author(s) 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Research Article de Jonge, Linda de Walle, Hermien E. K. de Jong-van den Berg, Lolkje T. W. van Langen, Irene M. Bakker, Marian K. Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title | Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title_full | Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title_fullStr | Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title_full_unstemmed | Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title_short | Actual Use of Medications Prescribed During Pregnancy: A Cross-Sectional Study Using Data from a Population-Based Congenital Anomaly Registry |
title_sort | actual use of medications prescribed during pregnancy: a cross-sectional study using data from a population-based congenital anomaly registry |
topic | Original Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4513216/ https://www.ncbi.nlm.nih.gov/pubmed/26041497 http://dx.doi.org/10.1007/s40264-015-0302-z |
work_keys_str_mv | AT dejongelinda actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry AT dewallehermienek actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry AT dejongvandenberglolkjetw actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry AT vanlangenirenem actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry AT bakkermariank actualuseofmedicationsprescribedduringpregnancyacrosssectionalstudyusingdatafromapopulationbasedcongenitalanomalyregistry |